Table 2. Comparison of demographic and clinical parameters between survivors and nonsurvivors.
| Variables | Survivors (n=28) | Nonsurvivors (n=9) | p-value | |
|---|---|---|---|---|
| Age at admission (month)* | 63 (3–172) | 6 (5–84) | 0.42 | |
| Sex (female n/%, male n/%) | 10 (35.7%), 18 (64.3%) | 3 (33.3%), 6 (66.7%) | 0.95 | |
| Weight at admission (kg)* | 15 (3–65) | 6 (5–24) | 0.56 | |
| Systolic blood pressure at admission (mmHg) | 94.5±18.1 | 65.0±6.2 | <0.001 | |
| Primary diagnosis | ||||
| Sepsis | 9 (32.1%) | 6 (66.7%) | 0.14 | |
| ATN | 11 (39.3%) | 1 (11.1%) | ||
| HUS | 4 (14.2%) | – | ||
| Metabolic disease | 2 (7.1%) | 1 (11.1%) | ||
| Intoxication | 2 (7.1%) | 0 | ||
| Bone marrow transplantation | – | 1 (11.1%) | ||
| Duration of ICU (day)* | 15 (2–62) | 5 (2–18) | 0.2 | |
| MV requirement | 17 (60.7%) | 9 (100%) | 0.52 | |
| Mechanical ventilation support | ||||
| CMV | 12 (42.9%) | 6 (66.6%) | 0.35 | |
| HFOV | 3 (10.7%) | 3 (33.3%) | ||
| NIV | 2 (7.1%) | 0 | ||
| PRISM III score | 10.3±6.6 | 18.3±0.57 | <0.001 | |
| Duration of RRT (day) | 5.6±3.6 | 2.6±1.1 | 0.18 | |
| Vasoactive inotropic drug | 7 (41.2%) | 3 (100%) | 0.03 | |
*
Indicates median (min–max).